中文 | English
Return
Total: 203 , 1/21
Show Home Prev Next End page: GO
MeSH:(Receptor, Angiotensin, Type 1)

2.Pharmacophore modeling of dual angiotensin II and endothelin A receptor antagonists.

Wei-Zhe XUE ; Wei LÜ ; Zhi-Ming ZHOU ; Zhan-Li WANG

Acta Pharmaceutica Sinica 2009;44(9):1002-1008

3.Effects of Angiotensin II on ZO-1 in Glomerular Epithelial Cells.

Hyun Hoe KOO ; Tae Sun HA

Korean Journal of Nephrology 2007;26(5):516-525

4.24-Hour blood pressure response to lower dose (30 mg) fimasartan in Korean patients with mild to moderate essential hypertension.

Hae Young LEE ; Cheol Ho KIM ; Jae Kwan SONG ; Shung Chull CHAE ; Myung Ho JEONG ; Dong Soo KIM ; Byung Hee OH

The Korean Journal of Internal Medicine 2017;32(6):1025-1036

5.Alteration of signal transduction-associated gene expression in rat cardiac fibroblasts induced by blocking angiotensin II receptors.

Xiao-Ying JIANG ; Guang-Dao GAO ; Xin-Feng WANG ; Yuan-Xi LIN ; Ya-Wen WANG ; Yu-Bai YANG

Acta Physiologica Sinica 2006;58(6):556-566

6.Association Analysis of a Polymorphism of the Angiotensin I-Converting Enzyme Gene and Angiotensin II Type 1 Receptor Gene in Korean Population.

Young Mok YANG

Journal of Genetic Medicine 1998;2(1):27-30

7.Role of angiotensin II receptors in proliferation of fibroblast derived from human hypertrophic scars.

Hong-wei LIU ; Biao CHENG ; Wen-Lin YU ; Rui-xia SUN ; Jian-bing TANG ; Xiao-bing FU

Chinese Journal of Plastic Surgery 2007;23(1):36-39

8.Differences of Angiotensin II receptor expression between systemic and pulmonary circulation in children with left-to-right shunt congenital cardiac lesions.

Li-Na QIAO ; Qi AN ; Tong-Fu ZHOU ; Qi ZHU ; Yi-Hong GUO ; Wen-Dong WANG

Chinese Journal of Contemporary Pediatrics 2006;8(1):27-29

9.Study on the relation between expression of angiotensin II receptor and apoptosis in myocardium in rats of endotoxemia.

Tie-hui XIAO ; Shi-wen WANG ; Yan-ming CHEN ; Qi CHEN ; Xin-yong ZHANG ; Ping YE

Chinese Journal of Applied Physiology 2012;28(3):275-279

10.Angiotensin II Type 1 Receptor Blocker, Fimasartan, Reduces Vascular Smooth Muscle Cell Senescence by Inhibiting the CYR61 Signaling Pathway

Inho KIM ; Chan Soon PARK ; Hae Young LEE

Korean Circulation Journal 2019;49(7):615-626

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 203 , 1/21 Show Home Prev Next End page: GO